British Journal of Medical & Surgical Urology
Volume 2, Issue 2 , Pages 62-66 , March 2009

Acute urinary morbidity during 3D conformal radiotherapy for localised prostate cancer

  • Helena P. Burden

      Affiliations

    • Department of Urology, Bristol Royal Infirmary, Bristol, UK
    • Corresponding Author InformationCorresponding author. Present address: Urology ST4, Department of Urology, Derriford Hospital, Plymouth PL68DH, UK. Tel.: +44 7977 412985; fax: +44 7977 412985.
    • ,
  • Simon Evans

      Affiliations

    • Department of Urology, Bristol Royal Infirmary, Bristol, UK
    • ,
  • Rob Jones

      Affiliations

    • Department of Urology, Bristol Royal Infirmary, Bristol, UK
    • ,
  • John Graham

      Affiliations

    • Bristol Haematology & Oncology Centre, Bristol, UK
    • ,
  • Raj Persad

      Affiliations

    • Department of Urology, Bristol Royal Infirmary, Bristol, UK

Received 13 August 2008 ,Revised 12 November 2008 ,Accepted 12 November 2008.

References 

  1. The American Urological Association Prostate Cancer Clinical Guidelines Panel. The Management of localised prostate cancer. http://www.auanet.org/timssnet/products/guidelines/patient_guides/ProstCaptguide.pdf.
  2. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. New Eng J Med. 2005;352:1977–1984
  3. Pollack A, Zagars GK, Starkschall G, Childress CH, Kopplin S, Boyer AL, et al. Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. Int Radiat Oncol Biol Phys. 1996;34:555–564
  4. Koper PCM, Stroom JC, van Putten WL, Korevaar GA, Heijmen BJ, Wijnmaalen A, et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomised study. Int J Radiat Oncol Biol Phys. 1999;43:727–734
  5. Dearnaley DP, Khoo VS, Norman AR, Meyer L, Nahum A, Tait D, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. The Lancet. 1999;353:267–272
  6. Morris DE, Emami B, Mauch PM, Konski AA, Tao ML, Ng AK, et al. Evidence-based review of 3-D conformal radiotherapy for localised prostate cancer: an astro outcomes initiative. Int J Radiat Oncol Biol Phys. 2005;62:3–19
  7. McCloskey SA, Ellerbroek AA, McCarthy L, Malcolm AW, Tao ML, Wollman RC, et al. Treatment outcomes of 3-D conformal radiotherapy for localised prostate carcinoma. Cancer. 2004;101:2693–2700
  8. Zelefsky MJ, Cowen D, Fuks Z, Shike M, Burman C, Jackson A, et al. Long-term tolerance of high dose 3-D conformal radiotherapy in patients with localised prostate carcinoma. Cancer. 1999;85:2460–2468
  9. Chou RH, Wilder RB, Ji M, Ryu JK, Leigh BR, Earle JD, et al. Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy. Int J Radiat Oncol Biol Phys. 2000;47:115–119
  10. Karlsdottir A, Johannessen DC, Muren LP, Wentzel-Larsen T, Dahl O. Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer. Radiotherapy and Oncology. 2004;71:43–53
  11. Do V, Choo R, Deboer G, Herschom S, Danjoux C, Chen CH, et al. Urodynamic findings 3 months after radiotherapy in patients treated with conformal external beam radiotherapy for prostate carcinoma. BJU Int. 2002;90:62–67
  12. Barry MJ, Fowler FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The measurement committee of the American Urological Association. J Urol. 1992;148:1549–1557
  13. Lee WR, McQuellon RP, Harris-Henderson K, Case LD, McCullough DL. A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 2000;46:77–81
  14. Lilleby W, Fossa SD, Waehre HR, Olsen DR. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys. 1999;43:735–743
  15. International Commission on radiation Units and Measurements. Prescribing, recording, and reporting photon beam therapy. ICRU report 50. Bethesda, MD; 1993.
  16. Zelefesky MJ, Aschkenasy E, Kelsen S, Leibel SA. Tolerance and early outcome results of post-prostatectomy three dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 1997;39:327–333

PII: S1875-9742(08)00119-5

doi: 10.1016/j.bjmsu.2008.11.008

British Journal of Medical & Surgical Urology
Volume 2, Issue 2 , Pages 62-66 , March 2009

Article Tools

* Image Usage & Resolution